Anesthetics and Analgesics in Children
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-17
SponsorChi Dang Hornik
About this trial
The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.
Eligibility criteria
Qualifiers
0 to <18 years of age at time of enrollment (must see applicable appendix for details as not all appendices enroll across the entire age range)
Parent and/or participant (if applicable) is able to understand the consent process and provides informed consent and HIPAA Authorization (if applicable)
Participant provides assent as required by the institutional review board (IRB) or research ethics board (REB)
Receiving one or more drugs of interest (DOI) per local standard of care
Disqualifiers
Known pregnancy
Extracorporeal life support (i.e., ECMO, dialysis, ventricular assist device)
Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study
Trial design
Treatments tested in this trial
- Ketorolac Tromethamine
- Hydromorphone
- Ketamine
- Oxycodone
- Morphine
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov